Endoscopic third ventriculostomy in patients with myelomeningocele after shunt failure

Purpose Myelomeningocele (MMC) is the most frequent form of spina bifida. Moreover, 90% of patients with MMC have hydrocephalus and require shunt placement. However, shunt failure management in such patients typically involves several shunt revisions, increasing the risk for morbidity and mortality....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Child's nervous system 2020-12, Vol.36 (12), p.3047-3052
Hauptverfasser: Furtado, Leopoldo Mandic Ferreira, da Costa Val Filho, José Aloysio, Holliday, Julia Braga, da Silva Costa, Júlia, de Matos, Marcelle Amaral, Nascimento, Victor Adalberto Machado, Ramos Cavalcanti, Túlio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3052
container_issue 12
container_start_page 3047
container_title Child's nervous system
container_volume 36
creator Furtado, Leopoldo Mandic Ferreira
da Costa Val Filho, José Aloysio
Holliday, Julia Braga
da Silva Costa, Júlia
de Matos, Marcelle Amaral
Nascimento, Victor Adalberto Machado
Ramos Cavalcanti, Túlio
description Purpose Myelomeningocele (MMC) is the most frequent form of spina bifida. Moreover, 90% of patients with MMC have hydrocephalus and require shunt placement. However, shunt failure management in such patients typically involves several shunt revisions, increasing the risk for morbidity and mortality. In this study, we report our experience with endoscopic third ventriculostomy (ETV) in MMC patients with shunts in a Brazilian institution. Methods Patients with MMC who presented with shunt failure and underwent ETV alone between January 1996 and December 2016 were included in this study. Patients who had undergone endoscopic choroid plexus cauterization (CPC) or had non-shunted MMC hydrocephalus were excluded. Various data related to the ETV procedure were collected for each patient, including features, operative characteristics, complications, and ETV success. The follow-up period for the patients was 6–12 months. ETV success scores (ETVSSs) were calculated retrospectively for each patient to compare the predicted success of the procedure with the actual success at 6 months after ETV. Results Forty-three MMC patients with shunt failure were included in this study. Of them, 16 (37.2%) had a previous central nervous system (CNS) infection and 4 (9.3%) had complications. Two neuroendoscopies were interrupted, one because of anatomic impossibility due to thickening of the interthalamic adhesion, obliterating the floor of the third ventricle, and another because of intraoperative hemorrhage. One patient developed hyponatremia during the postoperative period, whereas another developed reversible paresis of the oculomotor nerve. The ETVSS predicted a success rate of 49.6% compared with the actual ETV success rate of 53.48% (23 patients) at 6 months. At 12 months, the actual success rate was 41.9% (18 patients). All patients survived the procedure. Conclusion Our findings indicate that ETV is an effective procedure for managing MMC-related hydrocephalus after shunt failure. The expertise of the neurosurgeon in neuroendoscopy procedures is often the deciding factor when choosing a management option. Accordingly, less experienced neurosurgeons should be warned of the risks of this procedure.
doi_str_mv 10.1007/s00381-020-04596-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2386430273</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2386430273</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-e3153289e2ff86e38ca7ce0c48ec467e3a84f554988425405a03be0d538c829f3</originalsourceid><addsrcrecordid>eNp9kD1PAzEMhiMEglL4AwwoI8uBLx936YgQXxISC7BGaeprg-6SkuRA_fcECoxMluzHr-yHkJMazmuA9iIBcFVXwKACIWdNJXfIpBacV8Al7JIJMNlULQg4IIcpvQLUUrHZPjngjAnFWjUhL9d-EZINa2dpXrm4oO_oc3R27EPKYdhQ5-naZFe6iX64vKLDBvswoHd-GSz2SE2XMdK0Gn2mnXH9GPGI7HWmT3j8U6fk-eb66equeni8vb-6fKgsF22ukNeSMzVD1nWqQa6saS2CFQqtaFrkRolOSjFTSjApQBrgc4SFLGT5pONTcrbNXcfwNmLKenCpHNUbj2FMmnHVCA6s5QVlW9TGkFLETq-jG0zc6Br0l0-99amLT_3tU8uydPqTP84HXPyt_AosAN8CqYz8EqN-DWP05ef_Yj8BAOOBmg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2386430273</pqid></control><display><type>article</type><title>Endoscopic third ventriculostomy in patients with myelomeningocele after shunt failure</title><source>SpringerLink Journals - AutoHoldings</source><creator>Furtado, Leopoldo Mandic Ferreira ; da Costa Val Filho, José Aloysio ; Holliday, Julia Braga ; da Silva Costa, Júlia ; de Matos, Marcelle Amaral ; Nascimento, Victor Adalberto Machado ; Ramos Cavalcanti, Túlio</creator><creatorcontrib>Furtado, Leopoldo Mandic Ferreira ; da Costa Val Filho, José Aloysio ; Holliday, Julia Braga ; da Silva Costa, Júlia ; de Matos, Marcelle Amaral ; Nascimento, Victor Adalberto Machado ; Ramos Cavalcanti, Túlio</creatorcontrib><description>Purpose Myelomeningocele (MMC) is the most frequent form of spina bifida. Moreover, 90% of patients with MMC have hydrocephalus and require shunt placement. However, shunt failure management in such patients typically involves several shunt revisions, increasing the risk for morbidity and mortality. In this study, we report our experience with endoscopic third ventriculostomy (ETV) in MMC patients with shunts in a Brazilian institution. Methods Patients with MMC who presented with shunt failure and underwent ETV alone between January 1996 and December 2016 were included in this study. Patients who had undergone endoscopic choroid plexus cauterization (CPC) or had non-shunted MMC hydrocephalus were excluded. Various data related to the ETV procedure were collected for each patient, including features, operative characteristics, complications, and ETV success. The follow-up period for the patients was 6–12 months. ETV success scores (ETVSSs) were calculated retrospectively for each patient to compare the predicted success of the procedure with the actual success at 6 months after ETV. Results Forty-three MMC patients with shunt failure were included in this study. Of them, 16 (37.2%) had a previous central nervous system (CNS) infection and 4 (9.3%) had complications. Two neuroendoscopies were interrupted, one because of anatomic impossibility due to thickening of the interthalamic adhesion, obliterating the floor of the third ventricle, and another because of intraoperative hemorrhage. One patient developed hyponatremia during the postoperative period, whereas another developed reversible paresis of the oculomotor nerve. The ETVSS predicted a success rate of 49.6% compared with the actual ETV success rate of 53.48% (23 patients) at 6 months. At 12 months, the actual success rate was 41.9% (18 patients). All patients survived the procedure. Conclusion Our findings indicate that ETV is an effective procedure for managing MMC-related hydrocephalus after shunt failure. The expertise of the neurosurgeon in neuroendoscopy procedures is often the deciding factor when choosing a management option. Accordingly, less experienced neurosurgeons should be warned of the risks of this procedure.</description><identifier>ISSN: 0256-7040</identifier><identifier>EISSN: 1433-0350</identifier><identifier>DOI: 10.1007/s00381-020-04596-5</identifier><identifier>PMID: 32248278</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Medicine ; Medicine &amp; Public Health ; Neurosciences ; Neurosurgery ; Original Article</subject><ispartof>Child's nervous system, 2020-12, Vol.36 (12), p.3047-3052</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-e3153289e2ff86e38ca7ce0c48ec467e3a84f554988425405a03be0d538c829f3</citedby><cites>FETCH-LOGICAL-c347t-e3153289e2ff86e38ca7ce0c48ec467e3a84f554988425405a03be0d538c829f3</cites><orcidid>0000-0001-9472-9895</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00381-020-04596-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00381-020-04596-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32248278$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Furtado, Leopoldo Mandic Ferreira</creatorcontrib><creatorcontrib>da Costa Val Filho, José Aloysio</creatorcontrib><creatorcontrib>Holliday, Julia Braga</creatorcontrib><creatorcontrib>da Silva Costa, Júlia</creatorcontrib><creatorcontrib>de Matos, Marcelle Amaral</creatorcontrib><creatorcontrib>Nascimento, Victor Adalberto Machado</creatorcontrib><creatorcontrib>Ramos Cavalcanti, Túlio</creatorcontrib><title>Endoscopic third ventriculostomy in patients with myelomeningocele after shunt failure</title><title>Child's nervous system</title><addtitle>Childs Nerv Syst</addtitle><addtitle>Childs Nerv Syst</addtitle><description>Purpose Myelomeningocele (MMC) is the most frequent form of spina bifida. Moreover, 90% of patients with MMC have hydrocephalus and require shunt placement. However, shunt failure management in such patients typically involves several shunt revisions, increasing the risk for morbidity and mortality. In this study, we report our experience with endoscopic third ventriculostomy (ETV) in MMC patients with shunts in a Brazilian institution. Methods Patients with MMC who presented with shunt failure and underwent ETV alone between January 1996 and December 2016 were included in this study. Patients who had undergone endoscopic choroid plexus cauterization (CPC) or had non-shunted MMC hydrocephalus were excluded. Various data related to the ETV procedure were collected for each patient, including features, operative characteristics, complications, and ETV success. The follow-up period for the patients was 6–12 months. ETV success scores (ETVSSs) were calculated retrospectively for each patient to compare the predicted success of the procedure with the actual success at 6 months after ETV. Results Forty-three MMC patients with shunt failure were included in this study. Of them, 16 (37.2%) had a previous central nervous system (CNS) infection and 4 (9.3%) had complications. Two neuroendoscopies were interrupted, one because of anatomic impossibility due to thickening of the interthalamic adhesion, obliterating the floor of the third ventricle, and another because of intraoperative hemorrhage. One patient developed hyponatremia during the postoperative period, whereas another developed reversible paresis of the oculomotor nerve. The ETVSS predicted a success rate of 49.6% compared with the actual ETV success rate of 53.48% (23 patients) at 6 months. At 12 months, the actual success rate was 41.9% (18 patients). All patients survived the procedure. Conclusion Our findings indicate that ETV is an effective procedure for managing MMC-related hydrocephalus after shunt failure. The expertise of the neurosurgeon in neuroendoscopy procedures is often the deciding factor when choosing a management option. Accordingly, less experienced neurosurgeons should be warned of the risks of this procedure.</description><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Original Article</subject><issn>0256-7040</issn><issn>1433-0350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PAzEMhiMEglL4AwwoI8uBLx936YgQXxISC7BGaeprg-6SkuRA_fcECoxMluzHr-yHkJMazmuA9iIBcFVXwKACIWdNJXfIpBacV8Al7JIJMNlULQg4IIcpvQLUUrHZPjngjAnFWjUhL9d-EZINa2dpXrm4oO_oc3R27EPKYdhQ5-naZFe6iX64vKLDBvswoHd-GSz2SE2XMdK0Gn2mnXH9GPGI7HWmT3j8U6fk-eb66equeni8vb-6fKgsF22ukNeSMzVD1nWqQa6saS2CFQqtaFrkRolOSjFTSjApQBrgc4SFLGT5pONTcrbNXcfwNmLKenCpHNUbj2FMmnHVCA6s5QVlW9TGkFLETq-jG0zc6Br0l0-99amLT_3tU8uydPqTP84HXPyt_AosAN8CqYz8EqN-DWP05ef_Yj8BAOOBmg</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Furtado, Leopoldo Mandic Ferreira</creator><creator>da Costa Val Filho, José Aloysio</creator><creator>Holliday, Julia Braga</creator><creator>da Silva Costa, Júlia</creator><creator>de Matos, Marcelle Amaral</creator><creator>Nascimento, Victor Adalberto Machado</creator><creator>Ramos Cavalcanti, Túlio</creator><general>Springer Berlin Heidelberg</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9472-9895</orcidid></search><sort><creationdate>20201201</creationdate><title>Endoscopic third ventriculostomy in patients with myelomeningocele after shunt failure</title><author>Furtado, Leopoldo Mandic Ferreira ; da Costa Val Filho, José Aloysio ; Holliday, Julia Braga ; da Silva Costa, Júlia ; de Matos, Marcelle Amaral ; Nascimento, Victor Adalberto Machado ; Ramos Cavalcanti, Túlio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-e3153289e2ff86e38ca7ce0c48ec467e3a84f554988425405a03be0d538c829f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Original Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Furtado, Leopoldo Mandic Ferreira</creatorcontrib><creatorcontrib>da Costa Val Filho, José Aloysio</creatorcontrib><creatorcontrib>Holliday, Julia Braga</creatorcontrib><creatorcontrib>da Silva Costa, Júlia</creatorcontrib><creatorcontrib>de Matos, Marcelle Amaral</creatorcontrib><creatorcontrib>Nascimento, Victor Adalberto Machado</creatorcontrib><creatorcontrib>Ramos Cavalcanti, Túlio</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Child's nervous system</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Furtado, Leopoldo Mandic Ferreira</au><au>da Costa Val Filho, José Aloysio</au><au>Holliday, Julia Braga</au><au>da Silva Costa, Júlia</au><au>de Matos, Marcelle Amaral</au><au>Nascimento, Victor Adalberto Machado</au><au>Ramos Cavalcanti, Túlio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endoscopic third ventriculostomy in patients with myelomeningocele after shunt failure</atitle><jtitle>Child's nervous system</jtitle><stitle>Childs Nerv Syst</stitle><addtitle>Childs Nerv Syst</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>36</volume><issue>12</issue><spage>3047</spage><epage>3052</epage><pages>3047-3052</pages><issn>0256-7040</issn><eissn>1433-0350</eissn><abstract>Purpose Myelomeningocele (MMC) is the most frequent form of spina bifida. Moreover, 90% of patients with MMC have hydrocephalus and require shunt placement. However, shunt failure management in such patients typically involves several shunt revisions, increasing the risk for morbidity and mortality. In this study, we report our experience with endoscopic third ventriculostomy (ETV) in MMC patients with shunts in a Brazilian institution. Methods Patients with MMC who presented with shunt failure and underwent ETV alone between January 1996 and December 2016 were included in this study. Patients who had undergone endoscopic choroid plexus cauterization (CPC) or had non-shunted MMC hydrocephalus were excluded. Various data related to the ETV procedure were collected for each patient, including features, operative characteristics, complications, and ETV success. The follow-up period for the patients was 6–12 months. ETV success scores (ETVSSs) were calculated retrospectively for each patient to compare the predicted success of the procedure with the actual success at 6 months after ETV. Results Forty-three MMC patients with shunt failure were included in this study. Of them, 16 (37.2%) had a previous central nervous system (CNS) infection and 4 (9.3%) had complications. Two neuroendoscopies were interrupted, one because of anatomic impossibility due to thickening of the interthalamic adhesion, obliterating the floor of the third ventricle, and another because of intraoperative hemorrhage. One patient developed hyponatremia during the postoperative period, whereas another developed reversible paresis of the oculomotor nerve. The ETVSS predicted a success rate of 49.6% compared with the actual ETV success rate of 53.48% (23 patients) at 6 months. At 12 months, the actual success rate was 41.9% (18 patients). All patients survived the procedure. Conclusion Our findings indicate that ETV is an effective procedure for managing MMC-related hydrocephalus after shunt failure. The expertise of the neurosurgeon in neuroendoscopy procedures is often the deciding factor when choosing a management option. Accordingly, less experienced neurosurgeons should be warned of the risks of this procedure.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>32248278</pmid><doi>10.1007/s00381-020-04596-5</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9472-9895</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0256-7040
ispartof Child's nervous system, 2020-12, Vol.36 (12), p.3047-3052
issn 0256-7040
1433-0350
language eng
recordid cdi_proquest_miscellaneous_2386430273
source SpringerLink Journals - AutoHoldings
subjects Medicine
Medicine & Public Health
Neurosciences
Neurosurgery
Original Article
title Endoscopic third ventriculostomy in patients with myelomeningocele after shunt failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T22%3A53%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endoscopic%20third%20ventriculostomy%20in%20patients%20with%20myelomeningocele%20after%20shunt%20failure&rft.jtitle=Child's%20nervous%20system&rft.au=Furtado,%20Leopoldo%20Mandic%20Ferreira&rft.date=2020-12-01&rft.volume=36&rft.issue=12&rft.spage=3047&rft.epage=3052&rft.pages=3047-3052&rft.issn=0256-7040&rft.eissn=1433-0350&rft_id=info:doi/10.1007/s00381-020-04596-5&rft_dat=%3Cproquest_cross%3E2386430273%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2386430273&rft_id=info:pmid/32248278&rfr_iscdi=true